Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 11.42 1.78% 0.20
RXRX closed up 1.78 percent on Monday, March 18, 2024, on 1.51 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
7 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish 1.78%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.78%
Pocket Pivot Bullish Swing Setup 1.78%
Inside Day Range Contraction 1.78%

   Recent Intraday Alerts

Alert Time
Possible Pocket Pivot about 7 hours ago
50 DMA Support about 13 hours ago
50 DMA Resistance about 13 hours ago
2x Volume Pace about 13 hours ago
1.5x Volume Pace about 13 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare

Is RXRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.745
52 Week Low 4.54
Average Volume 7,547,560
200-Day Moving Average 9.26
50-Day Moving Average 11.29
20-Day Moving Average 12.30
10-Day Moving Average 11.09
Average True Range 1.15
RSI (14) 49.49
ADX 18.37
+DI 28.85
-DI 19.16
Chandelier Exit (Long, 3 ATRs) 12.28
Chandelier Exit (Short, 3 ATRs) 13.62
Upper Bollinger Bands 15.25
Lower Bollinger Band 9.35
Percent B (%b) 0.35
BandWidth 47.93
MACD Line -0.12
MACD Signal Line 0.10
MACD Histogram -0.2195
Fundamentals Value
Market Cap 2.38 Billion
Num Shares 208 Million
EPS -1.46
Price-to-Earnings (P/E) Ratio -7.82
Price-to-Sales 49.87
Price-to-Book 4.88
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.18
Resistance 3 (R3) 13.30 12.82 12.89
Resistance 2 (R2) 12.82 12.37 12.76 12.79
Resistance 1 (R1) 12.12 12.09 11.88 12.01 12.69
Pivot Point 11.65 11.65 11.53 11.59 11.65
Support 1 (S1) 10.95 11.20 10.71 10.83 10.15
Support 2 (S2) 10.47 10.92 10.41 10.05
Support 3 (S3) 9.77 10.47 9.95
Support 4 (S4) 9.66